Qualigen Therapeutics 10K 2022 Annual report | QLGN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: Abbott, accrete, Ackermann, acquiree, aim, alcohol, Aldrich, ALE, Allete, analyst, Andela, annum, antimicrobial, Arena, arose, Art, AST, Atlantic, attended, attrition, automation, Axon, Bachelor, background, banker, Becton, Bexcom, bifurcated, Bioengineering, Biographical, biomedical, biotech, Boston, Brown, CEO, chair, chromosome, citizen, clerical, COBRA, color, Colorado, Columbia, column, Commissioner, commodity, compatible, construe, contendere, conviction, crime, death, debenture, deep, defibrillator, dengue, detriment, detrimental, Dickinson, digital, Dillon, discharge, dishonesty, doctor, domiciled, driver, ECFMG, EDGAR, EMD, empowering, energy, entrepreneur, epidemic, equitable, erroneously, Excellence, exhaustive, factory, FDIC, fellow, felony, fifty, Fleet, flexibility, FMV, founder, Fractional, Francisco, fuel, gauge, Geffen, Genentech, Genyzyme, George, Goldman, Guidant, Hambrecht, Head, hereunder, host, Humanigen, hypothetical, IIA, Immunology, incentivize, incorrect, inflationary, instill, invaded, Israeli, IVDR, Jefferson, joined, joining, Jose, Jude, KGaA, Konrad, Lawrence, LGND, lieu, Ligand, lived, loading, Marshall, Martin, mathematical, MBA, media, membership, Michigan, midyear, military, MIT, MMM, Montgomery, moral, mortality, MTS, MTSC, nanomolar, nanosynex, narrative, Naval, Navy, nearest, NeuroCircuit, NIS, nolo, NYSE, ODD, oligonucleotide, oncologist, opine, overseeing, overseen, owner, pan, Pasteur, PDUFA, peer, PEO, percent, perspicuity, Pfizer, PhD, Philadelphia, philosophy, phosphoprotein, plea, POL, prefunded, premedical, premier, print, Prison, Professor, proforma, Punjab, purport, PVP, Quist, rationale, rebound, recession, refinance, rental, repatriation, repetitive, reprice, repriced, repricing, repurchase, repurchased, resignation, retention, RSU, RSV, San, Sanofi, SAR, School, SCT, Searle, sense, Serono, Shekel, Sigma, Silicon, Sloan, software, spent, spouse, St, staffing, Stanford, subsided, successor, sudden, surgery, surrendered, SVB, SynergenX, talent, talented, tangible, taxation, television, tenure, theft, TNBC, trajectory, transportation, trust, turpitude, UCLA, unchanged, uncured, undergraduate, underwritten, unpaid, urology, USA, USD, Valley, vehicle, Ventritex, vi, Vietnam, vii, viii, Viking, vital, vivo, VKTX, voluntarily, withheld, withholding, WR, xenograft, XOMA, Ziona

Removed: acquirer, adjust, anticipation, behalf, biology, call, clear, comparative, comparison, confirming, correct, deficiency, discontinued, earliest, electronic, emerged, Extensible, extinguishment, Finally, grace, hereof, herewith, hindsight, inadvertently, interrupt, introduced, Japan, judgement, Korea, Language, lawfully, merit, notifying, omitted, opening, partnering, payroll, physical, predicted, ratifying, refusal, representing, restate, restrictive, retrospective, revised, ROU, space, stringent, stronger, substitution, Subtopic, task, thereto, thereunto, therewith, trademark, undersigned, virtue, vitro, XBRL

Qualigen Therapeutics (QLGN) 10-K2022 FY Annual report

Content analysis